Kurs
-2,85%
Likviditet
0,06 MEUR
Kalender
| Est. tid* | ||
| 2026-11-06 | 08:00 | Kvartalsrapport 2026-Q3 |
| 2026-08-14 | 08:00 | Kvartalsrapport 2026-Q2 |
| 2026-05-08 | N/A | Årsstämma |
| 2026-05-06 | 08:00 | Kvartalsrapport 2026-Q1 |
| 2026-02-10 | N/A | Bokslutskommuniké 2025 |
| 2025-11-06 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-08-07 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-14 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2025-05-06 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-11-07 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-08 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-13 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2024-05-10 | - | Årsstämma |
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-11-03 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-04 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-11 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2023-05-10 | - | Årsstämma |
| 2023-05-05 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-11-03 | - | Kvartalsrapport 2022-Q3 |
| 2022-09-06 | - | Extra Bolagsstämma 2022 |
| 2022-08-04 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-11 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2022-05-10 | - | Årsstämma |
| 2022-05-05 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-04 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-05 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-29 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2021-04-28 | - | Årsstämma |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-11-25 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-27 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-12 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2020-06-11 | - | Årsstämma |
| 2020-05-29 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
Beskrivning
| Land | Finland |
|---|---|
| Lista | Small Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Optomed PlcStock Exchange Release7 June 2022 at 15.30, Helsinki
Changes in Optomed's Leadership Team
Sakari Knuutti has been appointed as interim Chief Financial Officer at Optomed as of 5 August 2022. Lars Lindqvist has decided that he will continue as Chief Financial Officer until 5 August 2022 after which he will support Sakari during a transition period of one month.
Sakari Knuutti joined Optomed in 2019 and currently he serves as the Chief Legal Officer and member of the leadership team at Optomed. He is responsible for legal affairs, quality & regulatory, investor relations and M&A all of which will continue to be under Sakari's responsibility in addition to the responsibilities of Chief Financial Officer.
"I want to thank Lars Lindqvist for his outstanding contributions to Optomed. Lars joined Optomed in 2019 as the CFO, and later during the same year he was one of the key persons taking the company public. Due to his contributions, we have now a well-functioning, competent finance team and well-established processes. Thanks to Lars, Optomed is now fundamentally stronger company." says Seppo Kopsala, CEO of Optomed.
Optomed Plc
Further enquiries
Seppo Kopsala, CEO, Optomed Plc, seppo.kopsala@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.
www.optomed.com